Professor Ferdinand Serracino-Inglott

Consultant Vascular Surgeon

MD, FRCSI, MSc, FRCS (Gen Surg)

Specialises in

  • Varicose vein treatment
  • Peripheral vascular disease
  • Venous disorders

I am a Consultant Vascular Surgeon at the Manchester Royal Infirmary. I was one of the first vascular surgeons to embrace minimally invasive techniques in the management of vascular disease.

I was one of the first consultants at Spire Manchester Hospital to carry out a VNUS procedure, and transformed the treatment of varicose veins from an inpatient procedure under a general anaesthetic with a painful protracted recovery to a minimally invasive treatment performed under local anaesthetic, as an outpatient procedure followed by a rapid, painless recovery.

I was also one of the first consultants to introduce branched and fenestrated stent-grafts to treat complex aneurysms of the aorta, remote endarterectomy for the minimally invasive treatment of blocked arteries in the leg to prevent amputations and outpatient treatment of varicose veins.

I am active in vascular research and I currently sit on the editorial board of the Annals of Vascular Surgery.


General Medical Council Number: 5206200

Treatment information

Some of the principal treatments carried out by Professor Ferdinand Serracino-Inglott at Spire include:

Vascular surgery

Other treatments

  • Angioplasty and stents
  • Carotid angioplasty and surgery for stroke prevention
  • Endovascular stent-graft treatment (EVAR/keyhole)
  • Open abdominal aortic aneurysms (EVAR)
  • Surgery for peripheral vascular disease
  • Venous disorders and varicose veins (laser and surgery)

Get in touch

Important information about Covid-19 tests

COVID-19 testing or antibody tests are not available as a standalone service at Spire Regency Hospital Macclesfield.


Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

Submit my enquiry

Additional information

Vascular surgery

Owns 100% of Sonosite Portable Ultrasound used at the hospital.
Owns 100% of Varilase Vascular Solutions used at the hospital.
Private secretary Gil Entwistle
Private secretary telephone 07842477572
Private secretary email